Medistim ASA
NOK 307.00NOK 0.00 (0.0%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
OSL · CODE.OL · NOK
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:40 AM UTC. Cached market data; not a live quote.
One-year closing-price history · NOK. Historical prices are not a forecast.
CodeLab Capital AS’s quoted price sits in the upper half of its reported 52-week range, 18.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CodeLab Capital AS’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CodeLab Capital AS offers cloud-based software services to healthcare professionals and their partners, with operations spanning Norway and global markets. The company's primary activity involves creating and continually enhancing the PatientSky cloud platform and its supporting technologies, all dedicated to improving patient care. Established in 2014, the firm is headquartered in Oslo, Norway, and was previously recognized as PatientSky Group AS.
Latest available per-share figures in NOK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| NOK 30.52M-34.02% vs estimate |
| Q1 2024 | May 7, 2024 | -NOK 0.11+95.6% vs estimate | NOK 60.67M+14.47% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NOK 307.00NOK 0.00 (0.0%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
NOK 10.42-NOK 0.12 (-1.14%)
Circio Holding ASA’s quoted price sits in the upper half of its reported 52-week range, 33.63% below the high.
NOK 25.80NOK 0.00 (0.0%)
Nordhealth AS’s quoted price sits in the lower half of its reported 52-week range, 32.81% below the high.
NOK 4.13-NOK 0.09 (-2.14%)
Thor Medical ASA’s quoted price sits in the lower half of its reported 52-week range, 42.06% below the high.
NOK 46.50-NOK 0.20 (-0.43%)
Photocure ASA’s quoted price sits in the lower half of its reported 52-week range, 41.73% below the high.
NOK 3.06+NOK 0.04 (+1.32%)
Nykode Therapeutics AS’s quoted price sits in the lower half of its reported 52-week range, 41.15% below the high.
NOK 21.10-NOK 0.30 (-1.4%)
ArcticZymes Technologies ASA’s quoted price sits in the lower half of its reported 52-week range, 27.24% below the high.
NOK 45.00-NOK 1.00 (-2.17%)
Omda AS’s quoted price sits in the upper half of its reported 52-week range, 12.45% below the high.